大血管炎与炎症性肠病的关联:一项病例对照研究
这项多中心回顾性病例对照研究纳入39例大动脉炎合并炎症性肠病(TA-IBD)和12例巨细胞动脉炎合并炎症性肠病(GCA-IBD)患者,对照为52例孤立性GCA和93例孤立性TA。TA-IBD患者诊断TA时更年轻且上肢跛行更多,GCA-IBD患者动脉增厚或狭窄更常见。多因素分析显示合并IBD与LVV复发率升高无关。
要点
- TA-IBD患者诊断TA时中位年龄27岁,较孤立性TA的37岁更年轻(P<0.001)。
- GCA-IBD患者动脉增厚或狭窄发生率75%,高于对照的30%(P=0.044)。
- 多因素分析中合并IBD与GCA复发风险无关(aHR 0.62 [0.13-2.83])。
核心结论
- 本研究识别出LVV-IBD患者特定的临床和影像学特征,尤其是GCA-IBD患者较孤立性GCA患者血管表现更严重。
研究设计与样本
- 观察性、多中心、回顾性病例对照研究;病例为来自欧洲国家的LVV-IBD患者,对照为孤立性LVV(iLVV)患者。
- 共纳入39例TA-IBD和12例GCA-IBD病例,对照为52例孤立性GCA(iGCA)和93例孤立性TA(iTA)。
主要发现
- LVV在IBD之后发生者占TA-IBD的56%、GCA-IBD的75%,中位间隔TA-IBD为1年(IQR 1-7)、GCA-IBD为8.6年(IQR 1-17.7)。
- TA-IBD中克罗恩病更常见(67%),GCA-IBD中溃疡性结肠炎更常见(58%)。
- 与iTA相比,TA-IBD诊断TA时更年轻(中位年龄27 vs 37岁,P<0.001)且上肢跛行更多(36% vs 12%,P=0.006)。
- GCA-IBD患者动脉增厚或狭窄较对照更常见(75% vs 30%,P=0.044),胃肠道动脉受累有更多趋势(20% vs 0%,P=0.06)。
- LVV可在IBD患者接受糖皮质激素(36%)、硫唑嘌呤(25%)或TNF-α抑制剂(29%)治疗期间发生。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To describe the characteristics and outcome of patients with the association of large vessel vasculitis (LVV, Takayasu arteritis [TA] or GCA) and IBD. METHODS: An observational, multicentre, retrospective case-control study. Cases were LVV-IBD patients from European countries, whereas controls had isolated LVV (iLVV). RESULTS: A total of 39 TA-IBD and 12 GCA-IBD cases were enrolled, compared with 52 isolated GCA (iGCA) and 93 isolated TA (iTA) controls. LVV occurred after IBD in 56% in TA-IBD and 75% in GCA-IBD, with a median interval of 1 year (interquartile range [IQR] 1-7) in TA-IBD and 8.6 years (IQR 1-17.7) in GCA-IBD. Crohn's disease was more common in TA-IBD (67%), whereas ulcerative colitis was more common in GCA-IBD (58%). Compared with iTA, TA-IBD were significantly younger at diagnosis of TA (median age 27 vs 37 years, P < 0.001) and had more upper limb claudication (36% vs 12%, P = 0.006). GCA-IBD patients had more frequent arterial thickening or stenosis than controls (75% vs 30%, respectively, P = 0.044) and tended to more frequently involve gastrointestinal arteries (20% vs 0%, respectively, P = 0.06). LVV occurred in IBD patients despite treatment with glucocorticoids (36%), azathioprine (25%) or TNF-alpha blockers (29%). The presence of the IBD was not associated with a higher LVV relapse rate in multivariate analysis (adjusted hazard ratio [aHR] 0.62 [0.13-2.83] for GCA and aHR 0.92 [0.44-1.89] for TA). CONCLUSION: This study identifies specific clinical and imaging characteristics of LVV-IBD patients, in particular a more severe vascular presentation of GCA-IBD patients compared with iGCA patients.
引用
- Maillet F, Nguyen Y, Espitia O, et al. Association between large vessel vasculitis and inflammatory bowel disease: a case-control study. Rheumatology (Oxford). 2025. PMID: 39898825. doi:10.1093/rheumatology/keaf030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。